ReviewJournal of gastrointestinal oncology2026
Deciphering the tubulin code: roles and mechanisms of microtubule post-translational modifications in gastrointestinal tumors: a narrative review.
Review in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Microtubules (MTs) are essential components of the cytoskeleton and regulate fundamental cellular processes, including cell division, maintenance of cell shape, and intracellular transport. Post-translational modifications (PTMs) of tubulin, such as acetylation, detyrosination, methylation, and polyglutamylation, diversify microtubule functions and constitute the "tubulin code". Increasing evidence suggests that dysregulated microtubule PTMs contribute to tumor progression. This review summarizes the clinical relevance, molecular mechanisms, and therapeutic potential of microtubule PTMs in gastrointestinal tumors. Methods: A narrative review was conducted using PubMed, EMBASE, Web of Science, and Google Scholar to identify relevant studies on microtubule PTMs in gastrointestinal tumors. Search terms included "microtubule", "tubulin", "post-translational modification", "acetylation", "detyrosination", "tyrosination", "polyglutamylation", "polyglycylation", "methylation", and "phosphorylation", together with terms related to gastrointestinal malignancies. Reference lists of relevant articles were also screened. Peer-reviewed original studies, relevant reviews, and representative translational reports were narratively synthesized according to clinical associations, molecular mechanisms, regulatory enzymes, and therapeutic implications. Key Content and Findings: Current evidence indicates that microtubule PTMs are closely involved in the progression of gastrointestinal tumors. Acetylation, detyrosination, methylation, and polyglutamylation regulate microtubule stability, intracellular transport, mitosis, migration, invasion, angiogenesis, mechanotransduction, and tumor microenvironment remodeling. Key regulatory enzymes, including HDAC6, αTAT1, TTL, TTLLs, and VASH1/2, have emerged as potential biomarkers and therapeutic targets in gastrointestinal malignancies. Conclusions: Microtubule PTMs represent an important regulatory layer in gastrointestinal tumor biology and may provide new opportunities for biomarker development and targeted therapy. However, their clinical application remains limited by insufficient tumor-specific validation and incomplete understanding of PTM crosstalk. Further studies integrating mechanistic investigation, large clinical cohorts, and multi-omics approaches are needed to promote translation of the tubulin code into precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.